Karyopharm Therapeutics
KPTI
KPTI
77 hedge funds and large institutions have $316M invested in Karyopharm Therapeutics in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 37 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
5% more funds holding
Funds holding: 73 → 77 (+4)
0.13% more ownership
Funds ownership: 3.93% → 4.06% (+0.13%)
Holders
77
Holding in Top 10
–
Calls
$1.3M
Puts
$123K
Top Buyers
| 1 | +$2.95M | |
| 2 | +$2.47M | |
| 3 | +$1.67M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.63M |
| 5 |
IHM
Iguana Healthcare Management
New York
|
+$1.1M |
Top Sellers
| 1 | -$3.48M | |
| 2 | -$823K | |
| 3 | -$452K | |
| 4 |
Barclays
London,
United Kingdom
|
-$325K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$222K |